R&D

We Strive for a Better Tomorrow and a Healthier Future.

AZB101

Project Target Indication Development Stage
AZB101 TYK2 Autoimmune Disease Candidate discovery in progress
  • Mechanism of Action

    AZB101 is designed to selectively target and inhibit TYK2-JH2, a mechanism linked to numerous autoimmune disorders, such as psoriasis.

  • Technical Advantage

    · AZB101 is a highly selective kinase inhibitor for TYK2-JH2.

    · AZB101 is being developed to be best-in-class with fewer side effects like JAK inhibitors.

    · AZB101 can be applied to a wide range of indications, including several immune-mediated diseases other than psoriasis.